KZA 0.00% 8.0¢ kazia therapeutics limited

Paxalisib GBM AGILE study, page-2

  1. 1,080 Posts.
    lightbulb Created with Sketch. 122
    Two Aussie biotechs with Capital Raises this week have resulted in their share price to increase, not slump like Kazias after its CR.
    I guess, its how the CR is managed, timed and executed that makes the difference

    Just my opinion, not advice
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.